This document is an agreement between Foundation Medicine, Inc. and Gates Ventures, LLC, granting Gates Ventures certain management rights in connection with their purchase of Series B Preferred Stock. The rights include quarterly telephone conferences and annual in-person meetings with the CEO, subject to confidentiality provisions. The agreement outlines conditions under which these rights terminate and specifies non-transferability except to affiliates. It also includes a clause regarding the involvement of the Bill & Melinda Gates Foundation.
documents/EFTA01100586.pdf
{}